glp-1 medications zepbound GLP1 Drug Use For Weight Loss Has Soared Costing Billions Lilly lowers self-pay prices of

It is contraindicated in patients with a personal or family history of medullary thyroid cancers (MTC) or patients with multiple endocrine neoplasia syndrome type 2 (MEN2).[30] FUTURE INDICATIONS AND TRIALS Oral semaglutide has been explored with higher doses of 25 and 50 mg in ongoing PIONEER plus trials.[39] Another trial under the name PIONEER TEEN is ongoing to see the efficacy and safety of semaglutide in children and teenagers with age 10 years to 17 years.[40] PIONEER REAL is a global prospective, non-interventional single-arm real-world study with oral semaglutide.[41] EVOKE and EVOKE plus are ongoing trials to see the effect of oral semaglutide in Alzheimers disease.[42] SOUL is an ongoing CV superiority trial with an objective to prove CV benefits with this molecule

6ce) or motor deficits (Supplementary Fig

Natural product-derived components have also been identified as potential small-molecule GLP-1R agonists

In China, GLP-1s are not widely reimbursed, are expensive, and mostly prescribed for diabetes rather than cosmetic weight loss